Galectin Therapeutics Inc.
NASDAQ:GALTBiotechnology
Healthcare
$2.91 +1.62%
+$0.05 today
- Market cap
- $191.64M
- Beta
- 0.49
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$0.40
52W Low $1.85High $7.13
Volume 0.26M
Average 0.32M
Price history
Galectin Therapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-52.99%
Period high
$6.51
Period low
$2.08
Latest
$2.91
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| DEFA14A | Oct 13, 2026 | Oct 13, 2026 | |
| DEF 14A | Oct 13, 2026 | Oct 13, 2026 | |
| ARS | Oct 13, 2026 | Oct 13, 2026 | |
| PRE 14A | Oct 2, 2026 | Oct 2, 2026 | |
| 10-Q | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13D/A | Aug 4, 2026 | Aug 4, 2026 | |
| 8-K | Aug 4, 2026 | Aug 4, 2026 | |
| 4 | Aug 4, 2026 | Aug 4, 2026 | |
| 4 | Jul 16, 2026 | Jul 16, 2026 | |
| 4 | Jun 30, 2026 | Jun 30, 2026 | |
| 4 | Jun 30, 2026 | Jun 30, 2026 | |
| 4 | Jun 25, 2026 | Jun 25, 2026 | |
| 8-K | Jun 23, 2026 | Jun 23, 2026 | |
| 4 | May 28, 2026 | May 28, 2026 |
Competitors
Who does Galectin Therapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about GALT's filings, answered from its disclosures.
What is the latest GALT filing?
The latest filing shown is ARS dated Oct 13, 2026.
How many recent filings does GALT have?
Intrinsic Alpha currently shows 20 recent filings for GALT.
Continue the stock analysis
Jump to another research area for this company.